1
|
Global Burden of Disease Cancer
Collaboration, . Fitzmaurice C, Abate D, Abbasi N, Abbastabar H,
Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I,
et al: Global, regional, and national cancer incidence, mortality,
years of life lost, years lived with disability, and
disability-adjusted life-years for 29 cancer groups, 1990 to 2017:
A systematic analysis for the global burden of disease study. JAMA
Oncol. 5:1749–1768. 2019. View Article : Google Scholar : PubMed/NCBI
|
2
|
Segelman J, Akre O, Gustafsson UO, Bottai
M and Martling A: External validation of models predicting the
individual risk of metachronous peritoneal carcinomatosis from
colon and rectal cancer. Colorectal Dis. 18:378–385. 2016.
View Article : Google Scholar : PubMed/NCBI
|
3
|
de Neree Tot Babberich MPM, Detering R,
Dekker JWT, Elferink MA, Tollenaar RAEM, Wouters MWJM and Tanis PJ;
Dutch ColoRectal Audit Group, : Achievements in colorectal cancer
care during 8 years of auditing in the Netherlands. Eur J Oncol.
44:1361–1370. 2018. View Article : Google Scholar : PubMed/NCBI
|
4
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A III: Colon and rectum. AJCC Cancer Staging
Manual. 7th edition. Springer-Verlag; New York, NY: pp. 143–164.
2010
|
5
|
Gunderson LL, Jessup JM, Sargent DJ,
Greene FL and Stewart AK: Revised TN categorization for colon
cancer based on national survival outcomes data. J Clin Oncol.
28:264–271. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Frankel WL and Jin M: Serosal surfaces,
mucin pools, and deposits, oh my: Challenges in staging colorectal
carcinoma. Mod Pathol. 28 (Suppl 1):S95–S108. 2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Eom T, Lee Y, Kim J, Park I, Gwak G, Cho
H, Yang K, Kim K and Bae BN: Prognostic factors affecting
disease-free survival and overall survival in T4 colon cancer. Ann
Coloproctol. 37:259–265. 2021. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bastiaenen VP, Aalbers AGJ, Arjona-Sánchez
A, Bellato V, van der Bilt JDW, D'Hoore AD, Espinosa-Redondo E,
Klaver CEL, Nagtegaal ID, van Ramshorst B, et al: Risk of
metachronous peritoneal metastases in patients with pT4a versus
pT4b colon cancer: An international multicentre cohort study. Eur J
Surg Oncol. 47:2405–2413. 2021. View Article : Google Scholar : PubMed/NCBI
|
9
|
Hompes D, Tiek J, Wolthuis A, Fieuws S,
Penninckx F, Van Cutsem E and D'Hoore A: HIPEC in T4a colon cancer:
A defendable treatment to improve oncologic outcome? Ann Oncol.
23:3123–3129. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
van Santvoort HC, Braam HJ, Spekreijse KR,
Koning NR, de Bruin PC, de Vries Reilingh TS, Boerma D, Smits AB,
Wiezer MJ and van Ramshorst B: Peritoneal carcinomatosis in T4
colorectal cancer: Occurrence and risk factors. Ann Surg Oncol.
21:1686–1691. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Eveno C, Lefevre JH, Svrcek M, Bennis M,
Chafai N, Tiret E and Parc Y: Oncologic results after multivisceral
resection of clinical T4 tumors. Surgery. 156:669–675. 2014.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Kumamoto T, Toda S, Matoba S, Moriyama J,
Hanaoka Y, Tomizawa K, Sawada T and Kuroyanagi H: Short- and
long-term outcomes of laparoscopic multivisceral resection for
clinically suspected T4 colon cancer. World J Surg. 41:2153–2159.
2017. View Article : Google Scholar : PubMed/NCBI
|
13
|
UICC, . TNM Classification of Malignant
Tumours. 8th edition. John Wiley & Sons Ltd.; New York, NY:
2017
|
14
|
Shepherd NA, Baxter KJ and Love SB: The
prognostic importance of peritoneal involvement in colonic cancer:
A prospective evaluation. Gastroenterology. 112:1096–1102. 1997.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Compton C, Fenoglio-Preiser CM, Pettigrew
N and Fielding LP: American Joint Committee on cancer prognostic
factors consensus conference: Colorectal working group. Cancer.
8:1739–1757. 2000. View Article : Google Scholar
|
16
|
Keshava A, Chapuis PH, Chan C, Lin BP,
Bokey EL and Dent OF: The significance of involvement of a free
serosal surface for recurrence and survival following resection of
clinicopathological stage B and C rectal cancer. Colorectal Dis.
9:609–618. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Petrelli F, Tomasello G, Borgonovo K,
Ghidini M, Turati L, Dallera P, Passalacqua R, Sgroi G and Barni S:
Prognostic survival associated with left-sided vs right-sided colon
cancer: A systematic review and meta-analysis. JAMA Oncol.
3:211–219. 2017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Park JS, Huh JW, Park YA, Cho YB, Yun SH,
Kim HC, Lee WY and Chun HK: Prognostic comparison between mucinous
and nonmucinous adenocarcinoma in colorectal cancer. Medicine
(Baltimore). 94:e6582015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mayanagi S, Kashiwabara K, Honda M, Oba K,
Aoyama T, Kanda M, Maeda H, Hamada C, Sadahiro S, Sakamoto J, et
al: Risk factors for peritoneal recurrence in stage II to III colon
cancer. Dis Colon Rectum. 61:803–808. 2018. View Article : Google Scholar : PubMed/NCBI
|
20
|
Saito S, Akagi T, Katayama H, Wakabayashi
M, Inomata M, Yamamoto S, Ito M, Kinugasa Y, Egi H, Munakata Y, et
al: Identification of patient subgroups with unfavorable long-term
outcomes associated with laparoscopic surgery in a randomized
controlled trial comparing open and laparoscopic surgery for colon
cancer (Japan Clinical Oncology Group Study JCOG0404). Ann
Gastroenterol Surg. 5:804–812. 2021. View Article : Google Scholar : PubMed/NCBI
|
21
|
Huynh C, Minkova S, Kim D, Stuart H and
Hamilton TD: Laparoscopic versus open resection in patients with
locally advanced colon cancer. Surgery. 170:1610–1615. 2021.
View Article : Google Scholar : PubMed/NCBI
|